FOLD logo

Amicus Therapeutics, Inc. (FOLD) Cash From Operations

Annual CFO:

-$33.89M+$35.20M(+50.95%)
December 31, 2024

Summary

  • As of today, FOLD annual cash from operations is -$33.89 million, with the most recent change of +$35.20 million (+50.95%) on December 31, 2024.
  • During the last 3 years, FOLD annual cash from operations has risen by +$168.60 million (+83.26%).
  • FOLD annual cash from operations is now -323.08% below its all-time high of $15.19 million, reached on December 31, 2007.

Performance

FOLD Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Quarterly CFO:

-$26.53M-$34.28M(-441.92%)
June 30, 2025

Summary

  • As of today, FOLD quarterly cash from operations is -$26.53 million, with the most recent change of -$34.28 million (-441.92%) on June 30, 2025.
  • Over the past year, FOLD quarterly cash from operations has dropped by -$49.22 million (-216.90%).
  • FOLD quarterly cash from operations is now -162.54% below its all-time high of $42.41 million, reached on December 31, 2007.

Performance

FOLD Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

TTM CFO:

-$45.66M-$49.22M(-1381.72%)
June 30, 2025

Summary

  • As of today, FOLD TTM cash from operations is -$45.66 million, with the most recent change of -$49.22 million (-1381.72%) on June 30, 2025.
  • Over the past year, FOLD TTM cash from operations has dropped by -$3.76 million (-8.98%).
  • FOLD TTM cash from operations is now -313.66% below its all-time high of $21.37 million, reached on June 30, 2008.

Performance

FOLD TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

FOLD Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+51.0%-216.9%-9.0%
3Y3 Years+83.3%-67.2%+72.9%
5Y5 Years+86.5%+20.9%+81.1%

FOLD Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+83.3%-216.9%+67.2%-1381.7%+72.6%
5Y5-Yearat high+86.5%-216.9%+67.2%-1381.7%+81.1%
All-TimeAll-Time-323.1%+88.7%-162.5%+80.0%-313.7%+86.2%

FOLD Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.53M(-441.9%)
-$45.66M(-1381.7%)
Mar 2025
-
$7.76M(+298.1%)
$3.56M(+110.5%)
Dec 2024
-$33.89M(+50.9%)
-$3.92M(+83.0%)
-$33.89M(-27.8%)
Sep 2024
-
-$22.97M(-201.2%)
-$26.52M(+36.7%)
Jun 2024
-
$22.69M(+176.4%)
-$41.89M(+48.1%)
Mar 2024
-
-$29.70M(-958.7%)
-$80.72M(-16.8%)
Dec 2023
-$69.09M(+58.5%)
$3.46M(+109.0%)
-$69.09M(+54.9%)
Sep 2023
-
-$38.35M(-137.7%)
-$153.32M(-21.1%)
Jun 2023
-
-$16.13M(+10.7%)
-$126.60M(-0.2%)
Mar 2023
-
-$18.07M(+77.6%)
-$126.33M(+24.2%)
Dec 2022
-$166.57M(+17.7%)
-$80.77M(-594.8%)
-$166.57M(-6.6%)
Sep 2022
-
-$11.63M(+26.7%)
-$156.32M(+7.2%)
Jun 2022
-
-$15.86M(+72.8%)
-$168.39M(+10.6%)
Mar 2022
-
-$58.31M(+17.3%)
-$188.45M(+6.9%)
Dec 2021
-$202.49M(+13.2%)
-$70.51M(-197.5%)
-$202.49M(-11.4%)
Sep 2021
-
-$23.70M(+34.0%)
-$181.80M(+9.1%)
Jun 2021
-
-$35.92M(+50.4%)
-$200.11M(-1.2%)
Mar 2021
-
-$72.35M(-45.2%)
-$197.70M(+15.3%)
Dec 2020
-$233.29M(+6.8%)
-$49.82M(-18.6%)
-$233.29M(+3.3%)
Sep 2020
-
-$42.01M(-25.3%)
-$241.30M(+5.3%)
Jun 2020
-
-$33.52M(+68.9%)
-$254.84M(+8.9%)
Mar 2020
-
-$107.94M(-86.6%)
-$279.81M(-11.7%)
Dec 2019
-$250.42M(+16.5%)
-$57.83M(-4.1%)
-$250.42M(+1.1%)
Sep 2019
-
-$55.55M(+5.0%)
-$253.26M(+23.4%)
Jun 2019
-
-$58.48M(+25.5%)
-$330.47M(-0.5%)
Mar 2019
-
-$78.55M(-29.4%)
-$328.98M(-9.7%)
Dec 2018
-$299.95M(-39.2%)
-$60.68M(+54.3%)
-$299.95M(+4.2%)
Sep 2018
-
-$132.76M(-132.9%)
-$313.02M(-36.0%)
Jun 2018
-
-$56.99M(-15.1%)
-$230.22M(-7.0%)
Mar 2018
-
-$49.52M(+32.8%)
-$215.13M(+0.2%)
Dec 2017
-$215.49M(-43.1%)
-$73.74M(-47.6%)
-$215.49M(-24.0%)
Sep 2017
-
-$49.96M(-19.2%)
-$173.73M(-5.5%)
Jun 2017
-
-$41.91M(+16.0%)
-$164.65M(-5.9%)
Mar 2017
-
-$49.87M(-55.9%)
-$155.47M(-3.3%)
Dec 2016
-$150.53M(-50.3%)
-$31.98M(+21.8%)
-$150.53M(+2.3%)
Sep 2016
-
-$40.88M(-24.9%)
-$154.06M(-14.8%)
Jun 2016
-
-$32.73M(+27.2%)
-$134.20M(-8.1%)
Mar 2016
-
-$44.94M(-26.5%)
-$124.10M(-23.9%)
Dec 2015
-$100.14M
-$35.51M(-69.0%)
-$100.14M(-26.5%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$21.02M(+7.2%)
-$79.14M(-8.0%)
Jun 2015
-
-$22.64M(-7.9%)
-$73.24M(-17.3%)
Mar 2015
-
-$20.98M(-44.6%)
-$62.42M(-20.8%)
Dec 2014
-$51.67M(-12.8%)
-$14.51M(+4.1%)
-$51.67M(-14.1%)
Sep 2014
-
-$15.12M(-27.9%)
-$45.28M(-3.7%)
Jun 2014
-
-$11.82M(-15.6%)
-$43.67M(-3.7%)
Mar 2014
-
-$10.22M(-25.9%)
-$42.11M(+8.0%)
Dec 2013
-$45.79M(-35.7%)
-$8.12M(+39.9%)
-$45.79M(-1.7%)
Sep 2013
-
-$13.51M(-31.7%)
-$45.05M(-16.3%)
Jun 2013
-
-$10.26M(+26.2%)
-$38.73M(+2.2%)
Mar 2013
-
-$13.90M(-88.5%)
-$39.60M(-17.4%)
Dec 2012
-$33.74M(+31.7%)
-$7.37M(-2.4%)
-$33.74M(+13.2%)
Sep 2012
-
-$7.20M(+35.3%)
-$38.89M(+13.0%)
Jun 2012
-
-$11.13M(-38.5%)
-$44.68M(-1.2%)
Mar 2012
-
-$8.04M(+35.8%)
-$44.16M(+10.7%)
Dec 2011
-$49.42M(-253.4%)
-$12.52M(+3.6%)
-$49.42M(-240.0%)
Sep 2011
-
-$12.99M(-22.4%)
-$14.54M(-15.3%)
Jun 2011
-
-$10.61M(+20.3%)
-$12.61M(+9.0%)
Mar 2011
-
-$13.31M(-159.5%)
-$13.86M(+0.9%)
Dec 2010
-$13.98M(+67.8%)
$22.36M(+302.2%)
-$13.98M(+70.2%)
Sep 2010
-
-$11.06M(+6.7%)
-$46.94M(+0.9%)
Jun 2010
-
-$11.86M(+11.7%)
-$47.35M(-3.0%)
Mar 2010
-
-$13.43M(-26.8%)
-$45.95M(-5.9%)
Dec 2009
-$43.37M(-17.7%)
-$10.59M(+7.7%)
-$43.37M(+7.9%)
Sep 2009
-
-$11.47M(-9.7%)
-$47.08M(-8.9%)
Jun 2009
-
-$10.46M(+3.6%)
-$43.23M(-6.7%)
Mar 2009
-
-$10.85M(+24.1%)
-$40.52M(-9.9%)
Dec 2008
-$36.86M(-342.6%)
-$14.30M(-87.5%)
-$36.86M(-285.7%)
Sep 2008
-
-$7.63M(+1.5%)
$19.85M(-7.1%)
Jun 2008
-
-$7.74M(-7.6%)
$21.37M(+14.1%)
Mar 2008
-
-$7.20M(-117.0%)
$18.73M(+23.3%)
Dec 2007
$15.19M(+144.8%)
$42.41M(+794.8%)
$15.19M(+155.8%)
Sep 2007
-
-$6.10M(+41.2%)
-$27.22M(-28.9%)
Jun 2007
-
-$10.38M(+3.3%)
-$21.12M(-96.7%)
Mar 2007
-
-$10.74M
-$10.74M
Dec 2006
-$33.89M(-87.0%)
-
-
Dec 2005
-$18.12M(-96.3%)
-
-
Dec 2004
-$9.23M(-138.1%)
-
-
Dec 2003
-$3.88M
-
-

FAQ

  • What is Amicus Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly cash from operations year-on-year change?
  • What is Amicus Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. TTM cash from operations year-on-year change?

What is Amicus Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of FOLD is -$33.89M

What is the all-time high annual cash from operations for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual cash from operations is $15.19M

What is Amicus Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, FOLD annual cash from operations has changed by +$35.20M (+50.95%)

What is Amicus Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of FOLD is -$26.53M

What is the all-time high quarterly cash from operations for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly cash from operations is $42.41M

What is Amicus Therapeutics, Inc. quarterly cash from operations year-on-year change?

Over the past year, FOLD quarterly cash from operations has changed by -$49.22M (-216.90%)

What is Amicus Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of FOLD is -$45.66M

What is the all-time high TTM cash from operations for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high TTM cash from operations is $21.37M

What is Amicus Therapeutics, Inc. TTM cash from operations year-on-year change?

Over the past year, FOLD TTM cash from operations has changed by -$3.76M (-8.98%)
On this page